Presentation, diagnosis, and management of achalasia

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 8, 2013, Pages 887-897

  Pandolfino, John E ^a   Kahrilas, Peter J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARIUM; BOTULINUM TOXIN; BOTULINUM TOXIN A; ISOSORBIDE DINITRATE; NIFEDIPINE; SILDENAFIL; SYNAPTOSOMAL ASSOCIATED PROTEIN 25;

ALLGROVE SYNDROME; ARTICLE; CANCER EPIDEMIOLOGY; CHAGAS DISEASE; CHOLINERGIC NERVE CELL; CHOLINERGIC STIMULATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DOWN SYNDROME; DYSPHAGIA; ENDOSCOPIC ECHOGRAPHY; EOSINOPHILIC ESOPHAGITIS; ESOPHAGITIS; ESOPHAGOGRAPHY; ESOPHAGUS ACHALASIA; ESOPHAGUS DILATATION; ESOPHAGUS DYSPLASIA; ESOPHAGUS MANOMETRY; ESOPHAGUS OBSTRUCTION; ESOPHAGUS PRESSURE; ESOPHAGUS SPASM; FOLLOW UP; HERPES SIMPLEX; HIATUS HERNIA; HUMAN; IMMUNE RESPONSE; INCIDENCE; INFLAMMATION; INTESTINE PRESSURE; LONG TERM CARE; LOWER ESOPHAGUS SPHINCTER; LYMPHOCYTE; MEASLES; MYENTERIC PLEXUS; MYOTOMY; NERVE CELL; PARKINSON DISEASE; PATHOPHYSIOLOGY; PERISTALSIS; STENT; T LYMPHOCYTE; UPPER ESOPHAGUS SPHINCTER;

EGJ; EPT; ESOPHAGEAL PRESSURE TOPOGRAPHY; ESOPHAGOGASTRIC JUNCTION; HIGH-RESOLUTION MANOMETRY; HRM; INTEGRATED RELAXATION PRESSURE; IRP; LES; LOWER ESOPHAGEAL SPHINCTER; PER ORAL ENDOSCOPIC MYOTOMY; POEM;

ESOPHAGEAL ACHALASIA; ESOPHAGUS; HUMANS;

EID: 84880608153     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.01.032     Document Type: Article

References (58)

1. Bredenoord A.J., Fox M., Kahrilas P.J., et al. Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil 2012, 24(Suppl 1):57-65.
2. Goldblum J.R., Whyte R.I., Orringer M.B., et al. Achalasia: a morphologic study of 42 resected specimens. Am J Surg Pathol 1994, 18:327-337.
3. Boeckxstaens G.E. Achalasia: virus-induced euthanasia of neurons?. Am J Gastroenterol 2008, 103:1610-1612.
4. Jung K.W., Yoon I.J., Kim doH., et al. Genetic evaluation of ALADIN gene in early-onset achalasia and alacrima patients. Neurogastroenterol Motil 2011, 17:169-173.
5. Zárate N., Mearin F., Gil-Vernet J.M., et al. Achalasia and Down's syndrome: coincidental association or something else?. Am J Gastroenterol 1999, 94:1674-1677.
6. Johnston B.T., Colcher A., Li Q., et al. Repetitive proximal esophageal contractions: a new manometric finding and a possible further link between Parkinson's disease and achalasia. Dysphagia 2001, 16:186-189.
7. de Oliveira R.B., Rezende Filho J., Dantas R.O., et al. The spectrum of esophageal motor disorders in Chagas' disease. Am J Gastroenterol 1995, 90:1119-1124.
8. Behar J., Biancani P. Pathogenesis of simultaneous esophageal contractions in patients with motility disorders. Gastroenterology 1993, 105:111-118.
9. Kwiatek M.A., Post J., Pandolfino J.E., et al. Transient lower oesophageal sphincter relaxation in achalasia: everything but LOS relaxation. Neurogastroenterol Motil 2009, 21. 1294-e124.
10. Pandolfino J.E., Kwiatek M.A., Nealis T., et al. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology 2008, 135:1526-1533.
11. Tutuian R., Pohl D., Castell D.O., et al. Clearance mechanisms of the aperistaltic oesophagus: the "pump gun" hypothesis. Gut 2006, 55:584-585.
12. Mayberry J.F. Epidemiology and demographics of achalasia. Gastrointest Endosc Clin N Am 2001, 11:235-248.
13. Kessing B.F., Bredenoord A.J., Smout A.J. Erroneous diagnosis of gastroesophageal reflux disease in achalasia. Clin Gastroenterol Hepatol 2011, 9:1020-1024.
14. Pandolfino J.E., Kahrilas P.J. American Gastroenterological Association medical position statement: clinical use of esophageal manometry. Gastroenterology 2005, 128:207-208.
15. Staiano A., Clouse R.E. Detection of incomplete lower esophageal sphincter relaxation with conventional point-pressure sensors. Am J Gastroenterol 2001, 96:3258-3267.
16. Ghosh S.K., Pandolfino J.E., Rice J., et al. Impaired deglutitive EGJ relaxation in clinical esophageal manometry: a quantitative analysis of 400 patients and 75 controls. Am J Physiol Gastrointest Liver Physiol 2007, 293:G878-G885.
17. Galey K.M., Wilshire C.L., Niebisch S., et al. Atypical variants of classic achalasia are common and currently under-recognized: a study of prevalence and clinical features. J Am Coll Surg 2011, 213:155-161.
18. Hirano I., Tatum R.P., Shi G., et al. Manometric heterogeneity in patients with idiopathic achalasia. Gastroenterology 2001, 120:789-798.
19. Roman S., Zerbib F., Queneherve L., et al. The Chicago classification for achalasia in a French multicentric cohort. Dig Liver Dis 2012, 44:976-980.
20. Salvador R., Costantini M., Zaninotto G., et al. The preoperative manometric pattern predicts the outcome of surgical treatment for esophageal achalasia. J Gastrointest Surg 2010, 14:1635-1645.
21. Pratap N., Reddy D.N. Can achalasia subtyping by high-resolution manometry predict the therapeutic outcome of pneumatic balloon dilatation?. Author's reply. Neurogastroenterol Motil 2011, 17:205.
22. Min M., Peng L.H., Yang Y.S., et al. Characteristics of achalasia subtypes in untreated Chinese patients: a high-resolution manometry study. J Dig Dis 2012, 13:504-509.
23. Spechler S.J., Castell D.O. Classification of oesophageal motility abnormalities. Gut 2001, 49:145-151.
24. Lin Z., Kahrilas P.J., Roman S., et al. Refining the criterion for an abnormal integrated relaxation pressure in esophageal pressure topography based on the pattern of esophageal contractility using a classification and regression tree model. Neurogastroenterol Motil 2012, 24:e356-e363.
25. Bortolotti M., Mari C., Lopilato C., et al. Effects of sildenafil on esophageal motility of patients with idiopathic achalasia. Gastroenterology 2000, 118:253-257.
26. Pasricha P.J., Rai R., Ravich W.J., et al. Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology 1996, 110:1410-1415.
27. Annese V., Bassotti G., Coccia G., et al. A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia: GISMAD Achalasia Study Group. Gut 2000, 46:597-600.
28. Vaezi M.F., Richter J.E., Wilcox C.M., et al. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut 1999, 44:231-239.
29. Zaninotto G., Annese V., Costantini M., et al. Randomized controlled trial of botulinum toxin versus laparoscopic Heller myotomy for esophageal achalasia. Ann Surg 2004, 239:364-370.
30. Smith C.D., Stival A., Howell D.L., et al. Endoscopic therapy for achalasia before Heller myotomy results in worse outcomes than Heller myotomy alone. Ann Surg 2006, 243:579-584. discussion 84-86.
31. Spiess A.E., Kahrilas P.J. Treating achalasia: from whalebone to laparoscope. JAMA 1998, 280:638-642.
32. Lynch K.L., Pandolfino J.E., Howden C.W., et al. Major complications of pneumatic dilation and Heller myotomy for achalasia: single-center experience and systematic review of the literature. Am J Gastroenterol 2012, 107:1817-1825.
33. Farhoomand K., Connor J.T., Richter J.E., et al. Predictors of outcome of pneumatic dilation in achalasia. Clin Gastroenterol Hepatol 2004, 2:389-394.
34. Boeckxstaens G.E., Annese V., des Varannes S.B., et al. Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia. N Engl J Med 2011, 364:1807-1816.
35. Campos G.M., Vittinghoff E., Rabl C., et al. Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann Surg 2009, 249:45-57.
36. Vela M.F., Richter J.E., Khandwala F., et al. The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol 2006, 4:580-587.
37. Rawlings A., Soper N.J., Oelschlager B., et al. Laparoscopic Dor versus Toupet fundoplication following Heller myotomy for achalasia: results of a multicenter, prospective, randomized-controlled trial. Surg Endosc 2012, 26:18-26.
38. Stefanidis D., Richardson W., Farrell T.M., et al. SAGES guidelines for the surgical treatment of esophageal achalasia. Surg Endosc 2012, 26:296-311.
39. Pasricha P.J., Hawari R., Ahmed I., et al. Submucosal endoscopic esophageal myotomy: a novel experimental approach for the treatment of achalasia. Endoscopy 2007, 39:761-764.
40. Inoue H., Minami H., Kobayashi Y., et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy 2010, 42:265-271.
41. Inoue H., Kudo S.E. Per-oral endoscopic myotomy (POEM) for 43 consecutive cases of esophageal achalasia. Nihon Rinsho 2010, 68:1749-1752.
42. von Renteln D., Inoue H., Minami H., et al. Peroral endoscopic myotomy for the treatment of achalasia: a prospective single center study. Am J Gastroenterol 2012, 107:411-417.
43. Swanström L.L., Rieder E., Dunst C.M. A stepwise approach and early clinical experience in peroral endoscopic myotomy for the treatment of achalasia and esophageal motility disorders. J Am Coll Surg 2011, 213:751-756.
44. Hungness E.S., Teitelbaum E.N., Santos B.F., et al. Comparison of perioperative outcomes between peroral esophageal myotomy (POEM) and laparoscopic Heller myotomy. J Gastrointest Surg 2012, 17:228-235.
45. Li Y.D., Cheng Y.S., Li M.H., et al. Temporary self-expanding metallic stents and pneumatic dilation for the treatment of achalasia: a prospective study with a long-term follow-up. Dis Esophagus 2010, 23:361-367.
46. Vaezi M.F., Baker M.E., Achkar E., et al. Timed barium oesophagram: better predictor of long term success after pneumatic dilation in achalasia than symptom assessment. Gut 2002, 50:765-770.
47. Vaezi M.F., Baker M.E., Richter J.E. Assessment of esophageal emptying post-pneumatic dilation: use of the timed barium esophagram. Am J Gastroenterol 1999, 94:1802-1807.
48. Eckardt V.F., Aignherr C., Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology 1992, 103:1732-1738.
49. Nicodème F., de Ruigh A., Xiao Y., et al. A comparison of symptom severity and bolus retention to Chicago classification esophageal pressure topography metrics in patients with achalasia. Clin Gastroenterol Hepatol 2012, 11:131-137.
50. Dodds W.J., Stewart E.T., Kishk S.M., et al. Radiologic amyl nitrite test for distinguishing pseudoachalasia from idiopathic achalasia. AJR Am J Roentgenol 1986, 146:21-23.
51. Pandolfino J.E., Roman S., Carlson D., et al. Distal esophageal spasm in high-resolution esophageal pressure topography: defining clinical phenotypes. Gastroenterology 2011, 141:469-475.
52. Miller D.L., Allen M.S., Trastek V.F., et al. Esophageal resection for recurrent achalasia. Ann Thorac Surg 1995, 60:922-925. discussion 5-6.
53. Peters J.H., Kauer W.K., Crookes P.F., et al. Esophageal resection with colon interposition for end-stage achalasia. Arch Surg 1995, 130:632-636. discussion 6-7.
54. Eckardt V.F., Hoischen T., Bernhard G. Life expectancy, complications, and causes of death in patients with achalasia: results of a 33-year follow-up investigation. Eur J Gastroenterol Hepatol 2008, 20:956-960.
55. Vela M.F., Richter J.E., Wachsberger D., et al. Complexities of managing achalasia at a tertiary referral center: use of pneumatic dilatation, Heller myotomy, and botulinum toxin injection. Am J Gastroenterol 2004, 99:1029-1036.
56. Leeuwenburgh I., Scholten P., Alderliesten J., et al. Long-term esophageal cancer risk in patients with primary achalasia: a prospective study. Am J Gastroenterol 2010, 105:2144-2149.
57. Sandler R.S., Nyrén O., Ekbom A., et al. The risk of esophageal cancer in patients with achalasia: a population-based study. JAMA 1995, 274:1359-1362.
58. Hirota W.K., Zuckerman M.J., Adler D.G., et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 2006, 63:570-580.